(RTTNews) - MannKind (MNKD) announced that the FDA has approved an update to the Prescribing Information for Afrezza Inhalation Powder, revising recommendations for the starting mealtime dosage when ...
The updated labeling provides a new conversion chart for starting dosages when switching patients from subcutaneous mealtime insulin to Afrezza. The Food and Administration (FDA) has approved updated ...
Hosted on MSN
FDA approves Qelbree label update for ADHD treatment
ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...
MannKind Corporation (NASDAQ:MNKD) is one of the Stocks to Buy Under $10 with High Potential. On January 8, MannKind Corporation (NASDAQ:MNKD) provided business updates and highlighted 2026 growth ...
Hosted on MSN
Danielle VS ADOR Update: The KPop Artist Addresses Her Fans Directly For The First Time Since Leaving The Label
For the first time since her removal from NewJeans, Danielle has spoken directly to fans, framing her departure as a beginning rather than an end. On the evening of 12 January, Danielle appeared in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results